ScholarWorks@Hanyang University

Browsing by Lee, Woo JeAuthor

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
전체 가 나 다 라 마 바 사 아 자 차 카 타 파 하

Showing results 1 to 6 of 6

SCIESCOPUSKCI
2025 Clinical Practice Guidelines for Diabetes Management in Korea: Recommendation of the Korean Diabetes AssociationGo to Linkopen access

Kang, Shinae; Kang, Seon Mee; Choi, Jong Han; Ko, Seung-Hyun; Koo, Bo Kyung; Kwon, Hyuk-Sang; Kim, Mi Kyung; Kim, Sang Yong; Kim, Soo-Kyung; Kim, Young-Eun, et al.

ArticleIssue Date2025CitationDiabetes and Metabolism Journal, v.49, no.4, pp 582 - 783Publisher대한당뇨병학회
SCIESCOPUSKCI
Bridging Evidence and Practice: A Consensus Statement from the Korean Diabetes Association on Diabetes Screening, Pharmacological Treatment and Severe DiabetesGo to Linkopen access

Choi, Jong Han; Kang, Shinae; Kim, Soo-Kyung; Kim, Won Jun; Kim, Ji Min; Bae, Jaehyun; Yun, Jae-Seung; Jeon, Eonju; Kim, Young-Eun; Bae, Jae Hyun, et al.

ArticleIssue Date2025CitationDIABETES & METABOLISM JOURNAL, v.49, no.6, pp 1155 - 1177PublisherKOREAN DIABETES ASSOC
SCIESCOPUS
Efficacy and safety of a fixed-dose combination of dapagliflozin and linagliptin (AJU-A51) in patients with type 2 diabetes mellitus: A multicentre, randomized, double-blind, parallel-group, placebo-controlled phase III studyGo to Linkopen access

Hong, Jun Hwa; Kim, Myung Jin; Min, Kyung Wan; Won, Jong Chul; Kim, Tae Nyun; Lee, Byung-Wan; Kang, Jun Goo; Kim, Jae Hyeon; Park, Jung Hwan; Ku, Bon Jeong, et al.

ArticleIssue Date2025CitationDIABETES OBESITY & METABOLISM, v.27, no.1, pp 81 - 91PublisherWILEY
SCIESCOPUS
Efficacy and Safety of Pioglitazone Add-on in Patients with Type 2 Diabetes Mellitus Inadequately Controlled with Metformin and Dapagliflozin: A Multicenter, Randomized, Double-blind, and Placebo-Controlled StudyGo to Linkopen access

Cho, Yun Kyung; Kim, Kyung-Soo; Lee, Byung-Wan; Hong, Jun Hwa; Yu, Jae Myung; Lim, Soo; Kim, Ye An; Lee, Chang Beom; Kim, Sang Soo; Kwak, Soo Heon, et al.

ArticleIssue Date2024CitationClinical Therapeutics, v.46, no.9, pp 662 - 669PublisherElsevier Inc.
SCIESCOPUS
Efficacy and safety of pioglitazone, empagliflozin and glimepiride as third-line agents in patients with type 2 diabetes inadequately controlled with metformin and DPP-4 inhibitors: A multicentre, phase 4 randomized controlled trialGo to Link

Cho, Yun Kyung; Cho, Jae-Hyoung; Hong, Sang-Mo; Park, Jung Hwan; Lee, Byung-Wan; Yoo, Jee Hee; Kim, Jae Hyeon; Chun, Sung Wan; Hwang, You-Cheol; Song, Kee-Ho, et al.

ArticleIssue Date2025CitationDiabetes, Obesity and Metabolism, v.27, no.11, pp 6375 - 6385PublisherBlackwell Publishing Inc.
SCIESCOPUSKCI
Metabolic Dysfunction-Associated Steatotic Liver Disease in Type 2 Diabetes Mellitus: A Review and Position Statement of the Fatty Liver Research Group of the Korean Diabetes AssociationGo to Linkopen access

Bae, Jaehyun; Han, Eugene; Lee, Hye Won; Park, Cheol-Young; Chung, Choon Hee; Lee, Dae Ho; Cho, Eun-Hee; Rhee, Eun-Jung; Park, Jung Hwan; Lee, Byung-Wan, et al.

ArticleIssue Date2024CitationDiabetes and Metabolism Journal, v.48, no.6, pp 1015 - 1028Publisher대한당뇨병학회
1
CONTACT US

RSS_1.0 RSS_2.0 ATOM_1.0

222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366

COPYRIGHT © 2024 HANYANG UNIVERSITY.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

한국어